Medtronic Letter to Patients
Medtronic, Inc. sent a letter out a few weeks ago to patients who still have the “recalled” Sprint Fidelis defibrillator leads in their chests. The letter claims that the risk to patients is relatively small. The letter from Reggie Groves, Vice President, Quality and Regulatory, claims that the “chance there will be a problem with your Sprint Fidelis lead remains small.”
Statistically speaking, Mr. Groves is correct. But using Medtronic’s own data, there is a 2.5% fracture risk at 30 months. No one knows yet the longer term risk for these Medtronic wires that were meant to be permanently implanted. What will the risk be at 60 months? Even at 2.5%, who wants potentially defective wires sending signals to their heart?
Miller & Zois’ defibrillator lead recall lawyers are reviewing both individual and class action defective Medtronic lead cases throughout the country. If you want to discuss your case with a Medtronic lead recall lawyer, call us for a free consultation at 800-553-8082 or click here for a free Internet consultation.
